Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.

Registrati

RZLT

Rezolute (RZLT)

Rezolute Inc

Da:

Notizie Regolamentate

Cerca Testo:

Ordina per:

Notizie Non Regolamentate

Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RZLT

1 2 3 4 Succ >>

Data	Ora	Fonte	Titolo	Simbolo	Compagnia
21/02/2025	01:59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:RZLT	Rezolute Inc
12/02/2025	22:28	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:RZLT	Rezolute Inc
12/02/2025	22:13	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:RZLT	Rezolute Inc
12/02/2025	22:05	GlobeNewswire Inc.	Rezolute Reports Second Quarter Fiscal 2025 Financial Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
04/02/2025	14:00	GlobeNewswire Inc.	Rezolute Provides Update on its Phase 3 sunRIZE Study of Ersodetug for the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism	NASDAQ:RZLT	Rezolute Inc
31/01/2025	14:00	GlobeNewswire Inc.	Rezolute to Participate in the Guggenheim SMID Cap Biotech Conference	NASDAQ:RZLT	Rezolute Inc
07/01/2025	14:00	GlobeNewswire Inc.	Rezolute Receives Breakthrough Therapy Designation from FDA for Ersodetug in the Treatment of Hypoglycemia Due to Congenital Hyperinsulinism	NASDAQ:RZLT	Rezolute Inc
30/12/2024	22:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:RZLT	Rezolute Inc
05/12/2024	14:00	GlobeNewswire Inc.	Rezolute Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:RZLT	Rezolute Inc
03/12/2024	14:00	GlobeNewswire Inc.	FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism	NASDAQ:RZLT	Rezolute Inc
15/11/2024	00:59	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:RZLT	Rezolute Inc
07/11/2024	22:05	GlobeNewswire Inc.	Rezolute Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
05/11/2024	14:00	GlobeNewswire Inc.	Rezolute to Participate in Upcoming Investor Conferences	NASDAQ:RZLT	Rezolute Inc
21/10/2024	22:43	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:RZLT	Rezolute Inc
21/10/2024	22:41	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:RZLT	Rezolute Inc
10/10/2024	22:40	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:RZLT	Rezolute Inc
19/09/2024	22:23	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:RZLT	Rezolute Inc
19/09/2024	22:05	GlobeNewswire Inc.	Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial Results and Provides Business Update	NASDAQ:RZLT	Rezolute Inc
09/09/2024	13:30	GlobeNewswire Inc.	FDA Lifts Partial Clinical Holds on RZ358 for the Treatment of Congenital Hyperinsulinism and Authorizes U.S. Inclusion in Ongoing Phase 3 Study	NASDAQ:RZLT	Rezolute Inc
15/08/2024	06:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:RZLT	Rezolute Inc
10/08/2024	03:47	Edgar (US Regulatory)	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	NASDAQ:RZLT	Rezolute Inc
05/08/2024	23:00	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:RZLT	Rezolute Inc
05/08/2024	13:30	GlobeNewswire Inc.	Rezolute Announces FDA Clearance of IND Application for Phase 3 Registrational Study of RZ358 for Treatment of Hypoglycemia Due to Tumor Hyperinsulinism	NASDAQ:RZLT	Rezolute Inc
31/07/2024	14:00	GlobeNewswire Inc.	Rezolute to Participate in the BTIG Virtual Biotechnology Conference	NASDAQ:RZLT	Rezolute Inc
27/06/2024	14:00	GlobeNewswire Inc.	Rezolute Announces Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement	NASDAQ:RZLT	Rezolute Inc
24/06/2024	14:00	GlobeNewswire Inc.	Rezolute Announces Closing of Public Offering with Approximately $60M in Gross Proceeds	NASDAQ:RZLT	Rezolute Inc
14/06/2024	22:49	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:RZLT	Rezolute Inc
14/06/2024	05:30	GlobeNewswire Inc.	Rezolute Announces Pricing of Public Offering of $60 Million of Common Stock and Pre-Funded Warrants	NASDAQ:RZLT	Rezolute Inc
13/06/2024	22:01	GlobeNewswire Inc.	Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants	NASDAQ:RZLT	Rezolute Inc
30/05/2024	14:00	GlobeNewswire Inc.	Rezolute to Participate in the Jefferies Global Healthcare Conference	NASDAQ:RZLT	Rezolute Inc

Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:RZLT

1 2 3 4 Succ >>

Pimco Exchange Traded

Cosco Shipping Internati... (PK)

Akuo Energy SAS 4.25% un...

Agricultural Credit 6.75...

Alliance Cargo Direct

Amundi Index Solutions (GM)

Delayed Upgrade Clock

Assistenza: help@advfn.com

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni